- Home
- NPKI vs ORIC Comparison
NPKI vs ORIC Comparison
Compare NPKI & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPKI
- ORIC
- Stock Information
- Founded
- NPKI 1932
- ORIC 2014
- Country
- NPKI United States
- ORIC United States
- Employees
- NPKI N/A
- ORIC N/A
- Industry
- NPKI Metal Fabrications
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- NPKI Industrials
- ORIC Health Care
- Exchange
- NPKI Nasdaq
- ORIC Nasdaq
- Market Cap
- NPKI 722.7M
- ORIC 362.9M
- IPO Year
- NPKI N/A
- ORIC 2020
- Fundamental
- Price
- NPKI $8.82
- ORIC $10.50
- Analyst Decision
- NPKI Strong Buy
- ORIC Strong Buy
- Analyst Count
- NPKI 1
- ORIC 8
- Target Price
- NPKI $12.00
- ORIC $18.83
- AVG Volume (30 Days)
- NPKI 943.8K
- ORIC 1.1M
- Earning Date
- NPKI 08-04-2025
- ORIC 08-11-2025
- Dividend Yield
- NPKI N/A
- ORIC N/A
- EPS Growth
- NPKI N/A
- ORIC N/A
- EPS
- NPKI N/A
- ORIC N/A
- Revenue
- NPKI $233,299,000.00
- ORIC N/A
- Revenue This Year
- NPKI $15.28
- ORIC N/A
- Revenue Next Year
- NPKI $9.62
- ORIC N/A
- P/E Ratio
- NPKI $17.95
- ORIC N/A
- Revenue Growth
- NPKI 312.30
- ORIC N/A
- 52 Week Low
- NPKI $4.76
- ORIC $3.90
- 52 Week High
- NPKI $8.88
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- NPKI N/A
- ORIC 70.83
- Support Level
- NPKI N/A
- ORIC $9.80
- Resistance Level
- NPKI N/A
- ORIC $11.19
- Average True Range (ATR)
- NPKI 0.00
- ORIC 0.61
- MACD
- NPKI 0.00
- ORIC -0.04
- Stochastic Oscillator
- NPKI 0.00
- ORIC 81.20
About NPKI NPK International Inc. Common Stock
NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.